|
2018
|
Invention
|
Humanized m-csf specific monoclonal antibodies, kits, and uses thereof. M-CSF-specific RX1-based ... |
|
2017
|
Invention
|
Angiogenically effective unit dose of fgf and method of administering.
The present invention pro... |
|
2016
|
Invention
|
M-csf specific monoclonal antibody and uses thereof. M-CSF-specific RX1-based or RX-1 derived ant... |
|
|
Invention
|
Antagonist anti-cd40 monoclonal antibodies and methods for their use.
Compositions and methods o... |
|
2015
|
Invention
|
M-csf specific monoclonal antibody and uses therof. M-CSF-specific RX1-based or RX-1 derived anti... |
|
2014
|
Invention
|
Alphavirus vectors for respiratory pathogen vaccines. Described herein are compositions and metho... |
|
|
Invention
|
Cell transfecting formulations of small interfering rna, related compositions and methods of maki... |
|
|
Invention
|
Angiogenically effective unit dose of fgf-2 and method of use.
The present invention provides a ... |
|
|
Invention
|
Endogenous retrovirus polypeptides linked to oncogenic transformation.
HERV-K human endogenous r... |
|
2013
|
Invention
|
Hiv-1 south african subtype c env proteins. The present invention relates to polynucleotides enco... |
|
|
Invention
|
Method of treating coronary artery disease by administering fgf-9. The present invention is direc... |
|
|
Invention
|
Group b streptococcus vaccine.
This application relates to improved Group B Streptococcus (“GBS”... |
|
|
Invention
|
Method for producing yeast expressed hpv types 6 and 16 capsid proteins.
Mosaic VLPs of viral ca... |
|
|
Invention
|
Method for preventing and treating cancer metastasis and bone loss associated with cancer metasta... |
|
2012
|
Invention
|
Methods and reagents for diagnosing hantavirus infection.
Novel methods and immunodiagnostic tes... |
|
|
Invention
|
Norovirus and sapovirus antigens. Immunogenic compositions that elicit immune responses against N... |
|
|
Invention
|
Compositions and methods for stimulating an immune response against infectious agents.
The inven... |
|
|
Invention
|
Microemulsions with adsorbed macromolecules and microparticles. Microparticles with adsorbent sur... |
|
|
Invention
|
Substituted imidazole derivates. The present invention relates to new substituted imidazole compo... |
|
|
Invention
|
Antagonist anti-cd40 monoclonal antibodies and methods for their use. Compositions and methods of... |
|
|
Invention
|
Nucleic acids and proteins from streptococcus groups a and b.
The invention provides proteins fr... |
|
|
Invention
|
Adjuvanted meningococcus compositions. A combination of CpG oligonucleotides and polymer micropar... |
|
|
Invention
|
Genes differentially expressed in breast cancer.
A polynucleotide sequence as shown in SEQ ID NO... |
|
|
Invention
|
Substituted benzazoles and methods of their use as inhibitors of raf kinase.
New substituted ben... |
|
|
Invention
|
Imidazoquinoline compounds.
The invention provides novel compositions comprising imidazoquinolin... |
|
|
Invention
|
Gene products differentially expressed in cancerous cells.
The present invention provides polynu... |
|
|
Invention
|
Use of tryptanthrin compounds for immune potentiation.
The invention provides immunostimulatory ... |
|
|
Invention
|
Expression of hiv polypeptides and production of virus-like particles.
The present invention rel... |
|
|
Invention
|
Method for the purification of alphavirus replicon particles.
Methods of production and purifica... |
|
|
Invention
|
Expression cassettes endcoding hiv-1 south african subtype c modified proteins.
The present inve... |
|
|
Invention
|
Mucosal boosting following parenteral priming.
Mucosal immunization using one or more antigens f... |
|
2011
|
Invention
|
Serum resistance factors of gram positive bacteria. A newly identified serum resistance factor of... |
|
|
Invention
|
Pancreatic cancer genes. The present invention provides the art with the DNA coding sequences of ... |
|
|
Invention
|
Hepatitis c receptor protein cd81.
The present invention relates to the use of CD81 protein and ... |
|
|
Invention
|
Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof. The pr... |
|
|
Invention
|
Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof.
The p... |
|
|
Invention
|
Production of alphavirus replicon particles in packaging cells.
Improvements in packaging cell s... |
|
|
Invention
|
Method of treating coronary artery disease fgf-2. The present invention provides a unit dose comp... |
|
|
Invention
|
Quinazolinone compounds as anticancer agents.
Quinazolinone compounds, pharmaceutically acceptab... |
|
|
Invention
|
Modified small interfering rna molecules and methods of use.
The present invention provides doub... |
|
2010
|
Invention
|
Method of treating coronary artery disease by administering fgf-5. The present invention is direc... |
|
|
Invention
|
Rsv f protein compositions amd methods for making same.
The present invention relates to immunog... |
|
2009
|
Invention
|
Alphavirus packaging cell lines.
This invention provides alphavirus packaging cell lines useful ... |
|
|
Invention
|
Two stage enrichment of cell-free fetal dna in maternal plasma.
The present invention provides m... |
|
2006
|
Invention
|
Mucosal and systemic immunization with alphavirus replicon particles.
Mucosal and systemic admin... |
|
2003
|
G/S
|
Medical blood testing equipment. |
